WASHINGTON (dpa-AFX) - Tuesday, Geron Corp. (GERN) disclosed the pricing of
an underwritten offering and pre-funded warrants.

The offering comprises 41,999,998 shares of its common stock at a rate of $3.00
per share and pre-funded warrants for the purchase of 8,002,668 shares of its
common stock at $2.999 per pre-funded warrant. Geron is planning to sell all the
securities in the offering.

The expected gross proceeds to Geron from this underwritten offering are around
$150.0 million.

The company plans to use the net proceeds from this offering, along with its
existing cash, for potential activities such as the commercialization of
imetelstat in specific syndromes in the U.S. and EU, pending regulatory
approvals. Additionally, the funds will support continued development and
potential regulatory submissions for imetelstat, with any remaining proceeds
allocated to working capital and general corporate expenses.

The offering is set to close around March 21, 2024, subject to customary closing
conditions.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX